Cargando…
Proapoptotic and antiinvasive activity of Rac1 small molecule inhibitors on malignant glioma cells
Malignant gliomas are characterized by an intrinsic ability to invade diffusely throughout the normal brain tissue. This feature contributes mainly to the failure of existing therapies. Deregulation of small GTPases signaling, in particular Rac1 activity, plays a key role in the invasive phenotype o...
Autores principales: | Cardama, Georgina A, Gonzalez, Nazareno, Ciarlantini, Matias, Gandolfi Donadío, Lucia, Comin, María Julieta, Alonso, Daniel F, Menna, Pablo Lorenzano, Gomez, Daniel E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4218912/ https://www.ncbi.nlm.nih.gov/pubmed/25378937 http://dx.doi.org/10.2147/OTT.S67998 |
Ejemplares similares
-
Preclinical Development of Novel Rac1-GEF Signaling Inhibitors using a Rational Design Approach in Highly Aggressive Breast Cancer Cell Lines
por: Cardama, Georgina A, et al.
Publicado: (2014) -
Pharmacological Rac1 inhibitors with selective apoptotic activity in human acute leukemic cell lines
por: Cabrera, Maia, et al.
Publicado: (2017) -
Preclinical Efficacy and Toxicology Evaluation of RAC1 Inhibitor 1A-116 in Human Glioblastoma Models
por: Cardama, Georgina A., et al.
Publicado: (2022) -
Computational and in vitro Pharmacodynamics Characterization of 1A-116 Rac1 Inhibitor: Relevance of Trp56 in Its Biological Activity
por: González, Nazareno, et al.
Publicado: (2020) -
Timing of Novel Drug 1A-116 to Circadian Rhythms Improves Therapeutic Effects against Glioblastoma
por: Trebucq, Laura Lucía, et al.
Publicado: (2021)